Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
 
Register now or login to post to this thread.

anyone for Zi Med. ? (ZIM)     

skyhigh - 15 Dec 2003 16:16

Is anyone into Zi Medical like me ? Gone up a penny today to 7.6p on strength of Sunday Telegraph article - it's looking better, at long last !

laurencecope - 15 Jan 2004 08:07 - 11 of 103

Company Zi Medical PLC
TIDM ZIM
Headline Product Launch
Released 07:00 15 Jan 2004
Number 2614U






Zi Medical plc ("Zi Medical or the Company")

UK Product Launch with Baxter Healthcare and

Discussions with Other Medical Device Companies

Zi Medical, the AIM quoted medical devices company, announced today that Baxter Healthcare Corporation ("Baxter") had officially launched the Red-Eye infusion monitor to the UK hospital market. The success of extensive field trials of the product in five major UK hospitals has led to this week's full roll-out to Baxter's UK sales force.

The Company further announces that it is in discussions with two other medical devices companies for the potential exploitation of its medication delivery system.

Michael Fort, Chairman, commented

"The development work carried out during the course of the last 12 months is beginning to bear fruit and Zi Medical has been in discussions with a number of businesses. We are pleased to be able to announce that Zi Medical has signed heads of terms with a large international company for the exclusive rights to a key product in our pipeline and we are confident that this will lead to a firm contract to commercially exploit the product later in the year."

Zi Medical signed an exclusive, global distribution agreement with Baxter in June 2003 for Red-Eye and the product launch in the UK is the companys first step in its strategy to launch a portfolio of innovative and technically superior products to the global healthcare market. Its strategy is to co-develop products in partnership with major medical devices companies who are well placed to achieve rapid penetration of the specialist medical devices market through their well established sales and marketing resources.

Michael Fort commented

"We are delighted to announce the launch of Red-Eye in the UK, the companys first major product to be exploited by a major device company. We are particularly pleased to be partnering a company of the calibre of Baxter whose sales presence in the global market is second to none. Both companies have put a serious effort into ensuring the marketing, training and support offered to customers with Red-Eye is first rate. Although it is too early to say what the financial impact of launch will be on the companys results, we are extremely optimistic that this will be a major contributor to the companys future profitability. In the meantime we will continue to work closely with Baxter to ensure the successful introduction of the product into the UK market."

Press Enquires:


Michael Fort, Executive Chairman,

Zi Medical PLC
Tel: 020 7448 1000

ZoBiddick, Biddicks
Tel: 020 7448 1000


Note to Editors

Red-Eye is an innovative patient monitoring device for the gravity-driven delivery of intravenous solutions. It monitors the safe delivery of intravenous solutions, and can equally be used for administering saline, pharmaceutical products and blood. Red-Eye works by setting off an alarm to alert nursing staff if the flow rate of intravenous fluids fluctuates beyond a predetermined range, thereby permitting staff to carry on other nursing duties. The device can be upgraded with a variety of features such as an illuminated alarm for night use or GSM capability to allow for home care patient monitoring.

END

skyhigh - 15 Jan 2004 09:08 - 12 of 103

Hi Lauren,
Thanks for this... looks good and price up a further 2.5p this morning..more to come over the next few weeks/months.. so I'm holding on to my holding of 20k shares for the time being (5k bought at 3.5p & 15k x 5.75p).. not bad going! long may it continue.. :)

skyhigh - 19 Jan 2004 09:17 - 13 of 103

Still doing well.. up another 2p today ! Plenty more upside to come thru. Going to keep running.. still lots more good news to come over the coming months on this one..:-)

Tech - 19 Jan 2004 10:42 - 14 of 103

Now up 3p. Agree that the upside could be very good. Mkt cap still small against potential.

skyhigh - 20 Jan 2004 09:20 - 15 of 103

Still going up ! another 2.25p this morning.... not complaining.. but how much more upside is there going to be ? :)

laurencecope - 20 Jan 2004 12:52 - 16 of 103

10% rise again today,.
What is everyone elses opinion of how far this is going in the next few weeks.

Caravaggio - 20 Jan 2004 14:12 - 17 of 103

skyhigh/laurencecope....In at 14 out at 20.5...remembering that old saying that no one ever made a loss taking profit..think the announcement of baxters and talking to others is now built into the SP...
Gem of a company but think it needs to pause for breath..
Good luck to those holding....class product/ distributer..could hit a 1 year end
C

Densil - 20 Jan 2004 17:31 - 18 of 103

Current upside target is 41p.
No sign of any trend reversal at the moment.
I'm in until it falters.

skyhigh - 21 Jan 2004 08:09 - 19 of 103

Densil,
I'm with you as I'm also in until it falters..Is the Current 41p upside target your target ? If not, where did it come from ? I got in at 3p & 6.5p so sitting nicely at the moment but would like to get out at the top. (where ever that is !)

Tech - 21 Jan 2004 08:38 - 20 of 103

Why look to get out at 41p. Further news is expected any moment. Upside over next 2 - 3 years could be well over a 1.

Still good time to buy if not in already.

skyhigh - 21 Jan 2004 08:44 - 21 of 103

Tech,
Agree with the 2/3 yr target >>> 1+
Do you know what the further news will be about ? and when ? are we talking this / next week ?
Cheers!...:)

Tech - 21 Jan 2004 09:38 - 22 of 103

From the recent RNS

"The development work carried out during the course of the last 12 months is
beginning to bear fruit and Zi Medical has been in discussions with a number of
businesses. We are pleased to be able to announce that Zi Medical has signed
heads of terms with a large international company for the exclusive rights to a
key product in our pipeline and we are confident that this will lead to a firm
contract to commercially exploit the product later in the year."

Zi Medical signed an exclusive, global distribution agreement with Baxter in
June 2003 for Red-Eye and the product launch in the UK is the company's first
step in its strategy to launch a portfolio of innovative and technically
superior products to the global healthcare market. Its strategy is to co-develop
products in partnership with major medical devices companies who are well placed
to achieve rapid penetration of the specialist medical devices market through
their well established sales and marketing resources.

To me the main points are that it says it is a global distribution agreement. Also the other products will be commercially exploited later in the year.

laurencecope - 21 Jan 2004 17:41 - 23 of 103

What a ride 24% up today

Tech - 21 Jan 2004 20:58 - 24 of 103

Nice bit about company from April 2002. Looks like things said at time were correct. Looking forward to further good news.

Red-Eye is the brainchild of inventor George Gallagher, founder of Zimed and now technical officer of the enlarged group. It uses fibre optics to monitor the dosage of fluids delivered to patients through intravenous drips - but without the lines having to be constantly checked by nursing staff. For hospitals, it saves valuable nursing time, works as an early warning system, and can prove itself to be more cost effective than traditional methods. For Zimedical it could be a very profitable opportunity.

The device has been designed from the bottom up, by talking with the nurses who monitor the patient's drip every-twenty minutes on a daily basis. The result is a product which it claims to have both nurses' and patients' needs in mind. Already approved as a class I medical device, all that remains is for the company to go out and sell it.

As yet, however, the marketing and sales force behind the product has been minimal. Gallagher has been operating as a one-man salesman in addition to his other management roles at the company. Even so, the product has been trialled in 59 hospitals - and 29 have gone on to purchase an average of just over 5 Red-Eye systems each. The others are still continuing trials. To date some 220 units have been sold. Sales for the 9 months to December 2001 amounted to 21,000.

An experienced sales force is now being put in place. The company is now raising 717,280 through a placing and open offer of new shares. The money is being used to hire a team of 12 full-time employees to build a national sales force. According to chairman Michael Fort, the contribution that the new team will make to sales should mean that the cash raised will be enough to see the group past break-even in around 15 months time.

There should also be funds available to speed other similar products down the pipeline. These include a catheter-monitoring product, a networked monitoring device and a fluid recognition product. The most fully developed, the Red Eye III catheter monitor, is expected to reach the market in just over 12 months.

azhar - 22 Jan 2004 11:51 - 25 of 103

Zi Medical PLC
22 January 2004


Zi Medical plc (the 'Company')

Proposed equity issue

Zi Medical plc, the specialist developer of innovative medical device
technologies with an emphasis on drug infusion therapy, announced today that the
Board is considering a further equity issue to strengthen the Company's balance
sheet, provide additional working capital to support the increase in turnover
expected following the launch of the Company's RedEye infusion device and to
support the Company's development of new products.

Whilst the Board is encouraged by the support for the Company's shares shown by
the Stock Market in recent days it is anticipated that if the proposed equity
issue proceeds it will be at a price lower than the current price quoted in the
market.

Executive Chairman, Michael Fort said:

'We are encouraged to see that the achievements of the Company have been
received with such great enthusiasm by investors. With the commercial launch of
the RedEye product, in partnership with Baxter Healthcare, we believe that the
Company has reached a stage in its commercial development where it would be
appropriate to seek further funding to facilitate the Company's future growth.'

azhar - 22 Jan 2004 11:54 - 26 of 103

I'd say time get out and take profit. Get back in later when we know what the issue price will be.

erenr - 22 Jan 2004 15:13 - 27 of 103

THEY WENT FROM 15% UP TO 24% DOWN TODAY NOW MAY BE A GOOD TIME TO GET IN 19.5P/22P SPREAD RATHER LARGE PUTS ME OFF THOUGH

Fundamentalist - 22 Jan 2004 19:21 - 28 of 103

Before buying read the following statement - i have been watching these but this has deterred me in the short term:

Zi Medical PLC - Proposed Equity Issue
RNS Number:5240UZi Medical PLC22 January 2004Zi Medical plc (the 'Company')Proposed equity issueZi Medical plc, the specialist developer of innovative medical devicetechnologies with an emphasis on drug infusion therapy, announced today that theBoard is considering a further equity issue to strengthen the Company's balancesheet, provide additional working capital to support the increase in turnoverexpected following the launch of the Company's RedEye infusion device and tosupport the Company's development of new products.Whilst the Board is encouraged by the support for the Company's shares shown bythe Stock Market in recent days it is anticipated that if the proposed equityissue proceeds it will be at a price lower than the current price quoted in themarket.Executive Chairman, Michael Fort said:'We are encouraged to see that the achievements of the Company have beenreceived with such great enthusiasm by investors. With the commercial launch ofthe RedEye product, in partnership with Baxter Healthcare, we believe that theCompany has reached a stage in its commercial development where it would beappropriate to seek further funding to facilitate the Company's future growth.'

erenr - 26 Jan 2004 13:06 - 29 of 103

true but the price that day i think was around 25/26p dipped my toes in today just 1 thousand at 17.5p I think it should go on to test 30p plus from here i did not expect to get the chance to buy in under 19p this to me is now a no brainer
IMHO

robstuff - 04 Feb 2004 14:56 - 30 of 103

Discusting - i didn't get offered any at 12p!
Register now or login to post to this thread.